Van Hulzen Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50	Closed	-$6.16K	–	713
2024 Q4	$6.16K	Buy	+50	New	+$5.89K	﹤0.01%	826
2023 Q1	–	Sell	-2,631	Closed	-$419K	–	314
2022 Q4	$419K	Buy	2,631 +109	+4%	+$16K	0.05%	195
2022 Q3	$336K	Sell	2,522 -3,145	-55%	-$478K	0.04%	200
2022 Q2	$884K	Sell	5,667 -412	-7%	-$63.4K	0.11%	118
2022 Q1	$946K	Buy	6,079 +207	+4%	+$30K	0.1%	118
2021 Q4	$748K	Buy	5,872 +1,095	+23%	+$144K	0.08%	138
2021 Q3	$622K	Buy	4,777 +1,931	+68%	+$292K	0.09%	121
2021 Q2	$506K	Buy	2,846 +189	+7%	+$32.7K	0.08%	147
2021 Q1	$437K	Buy	2,657 +40	+2%	+$6.58K	0.07%	159
2020 Q4	$432K	Buy	2,617 +98	+4%	+$14.6K	0.07%	159
2020 Q3	$359K	Buy	+2,519	New	+$312K	0.05%	172
2020 Q1	–	Sell	-10,460	Closed	-$1.56M	–	272
2019 Q4	$1.56M	Buy	+10,460	New	+$1.42M	0.3%	72